Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Paroxysmal Sympathetic Hyperactivity
Interventions: Percutaneous Electrical Nerve Field Stimulation (PENFS) device application; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 2 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Glaucoma
Interventions: Comparison of four visual field testing strategies; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Cancer, Hereditary Neoplasms, Genetic Predisposition to Cancer, Environment
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Year to 99 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2035
U.S. locations: 2
States / cities: Bethesda, Maryland • Rockville, Maryland

Conditions: Anxiety Disorders Generalized
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: Carmen Andreescu; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alzheimer's Disease
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), NICE Cognitive Training; Device · Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 55 Years to 90 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Aneurysm, AVM, Dural Arteriovenous Fistula, Glioma, Meningioma, Metastasis, Bypass
Interventions: Laser speckle contrast imaging (LSCI); Device
Lead sponsor: Dynamic Light; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease, Lymphoma: Hodgkin
Interventions: Vincristine, Cyclophosphamide, Doxorubicin, Prednisone, Bleomycin, Etoposide, Low-dose radiotherapy (RT); Drug · Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 2
States / cities: Stanford, California • Vallejo, California

Conditions: Medulloblastoma
Interventions: Cisplatin, Craniospinal Irradiation, Cyclophosphamide, Involved-Field Radiation Therapy, Laboratory Biomarker Analysis, Lomustine, Quality-of-Life Assessment, Radiation Therapy, Vincristine Sulfate; Drug · Radiation · Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: 3 Years to 21 Years
Enrollment: 549 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2024
U.S. locations: 174
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 132 more

Conditions: Weight Gain
Interventions: Prenatal yoga, Pregnancy education; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 46 Years · Female only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Phoenix, Arizona

Conditions: Esophageal Cancer, Lung Cancer, Lymphoma
Interventions: topotecan hydrochloride, low-LET electron therapy, low-LET photon therapy; Drug · Radiation
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2000
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: One Eye Blindness, Blind Left Eye, Blind Right Eye
Interventions: Multiplexing Prism; Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 16 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Metastatic Ocular Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8
Interventions: Ipilimumab, Nivolumab, Pembrolizumab, Stereotactic Radiosurgery, Tumor Treating Fields Therapy; Biological · Radiation · Procedure
Lead sponsor: Emory University; Other
Eligibility: 22 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetic Retinal Disease
Interventions: Visual Acuity, Reading Speed, Visual Field testing, Contrast sensitivity, Electroretinography (ERG) and pupillography in light- and dark-adapted states, Ultrawide field-color photograph, Ultrawide field-Fluorescein angiogram, Optical coherence tomography, Optical coherence tomography- Angiography; Diagnostic Test · Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 8
States / cities: Huntington Beach, California • Augusta, Georgia • Boston, Massachusetts + 5 more

Conditions: MDD
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Neuronetics; Other
Eligibility: 12 Years to 21 Years
Enrollment: 7,690 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Malvern, Pennsylvania

Conditions: Esophageal Carcinoma
Interventions: Cisplatin, Irinotecan, External Beam Radiation Therapy; Drug · Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Lymphoblastic Leukemia (ALL), Critical Illness, Physical Therapy Modalities, Occupational Therapy, Animal Assisted Therapy
Interventions: PARO therapy seal; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 5 Years to 18 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Depression, Treatment Resistant
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Metastatic Breast Cancer, Breast Cancer
Interventions: Pulsed Electric Field (PEF) System, Questionnaires, Tumor Ablation; Device · Behavioral · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Scrotal Pain
Interventions: Transcranial magnetic stimulation; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chronic Pain
Interventions: Intermittent Theta Burst Stimulation (iTBS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Full-thickness Rotator Cuff Tear
Interventions: RCStim Model 1114; Device
Lead sponsor: Orthofix Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 23
States / cities: Phoenix, Arizona • Redwood City, California • San Francisco, California + 17 more

Conditions: Histiocytosis
Interventions: Trail Making Test, Parts A & B, Brief Test of Attention, Symbol Span, Controlled Oral Word Association Test, The Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Hospital Anxiety and Depression Scale, McGill Quality of Life Scale, MR Brain Imaging, Resting state functional MRI, Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog); Behavioral · Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 4
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 1 more

Conditions: Parkinson Disease
Interventions: Rhythmic Auditory Stimulation (RAS); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children

Variability in Perimetry Study

Rare Tumors and Cancer Predisposition in Individuals and Families

A Pilot fMRI Study of TMS in Late-Life Severe Worry

Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients

Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke

Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow

Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Investigating the Feasibility and Preliminary Effects of Yoga on Excessive Gestational Weight Gain

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Multiplexing Prism Fitting for Field Expansion of Monocular Vision

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes

A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents

Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.

Animal Assisted Interactions With Animal Robot in the Intensive Care Unit (ICU)

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain

Accelerated Theta Burst in Chronic Pain: A Biomarker Study

PEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears

A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

Effects of RAS on Gait in PD Patients With DBS